drugset / Trial / NCT02190786
Phase II Exploratory Clinical Study of KUX-1151
Summary
The purpose of this study is to investigate the efficacy, safety and pharmacokinetics of multiple oral administration of KUX-1151 in patients with hyperuricemia including gout.
Timeline
- Start
- —
- Primary completion
- 2015-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KUX-1151 | Unknown | — | Oral |
Indications
No indication recorded.